-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Finishingrainbow
On the evening of August 5, it was reported that Pfizer Biopharmaceutical Group will appoint Peng Zhenke (JC) as the president of China.
The working hours will start on September 1, 2021, and the work location will be Beijing
.
After the appointment, Zhenke Peng will join the global leadership team of Pfizer Biopharmaceuticals and report to the group president Huang Weiming
Former China President Pierre Gaudreault (Pierre Gaudreault) will continue to return to the post of President of Emerging Markets Asia
Resume of Peng Zhenke:
Peng Zhenke's career began in Rhone-Poulenc Rorer (one of the predecessors of Sanofi) in the UK
In 1997, Peng Zhenke left Rhone Planck Le'an to join Parker David as the senior product manager of Lipitor
In 2000, Peng Zhenke joined BMS and was transferred to the Chinese market in 2011.
On March 3, 2015, Sanofi announced the appointment of Peng Zhenke as the general manager of business operations in China.
At the end of 2020, Peng Zhenke left Sanofi and became the founder and partner of INNOVie, a medical consulting company
Reference source: medical representative
